Kyverna Therapeutics, Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

Compare

7.80

-0.04 (-0.51%)

At close: Dec 5, 2025, 4:00 PM EST

7.65

-0.15 (-1.92%)

After-hours: Dec 5, 2025, 6:00 PM EST

Kyverna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.16	96.62	34.65	37.74	76.07
Short-Term Investments	136.97	189.36	22.9	13.59	-
Cash & Short-Term Investments	171.14	285.98	57.54	51.32	76.07
Cash Growth	-46.78%	396.98%	12.12%	-32.53%	-
Prepaid Expenses	3.79	4.62	3.12	1.93	1.02
Total Current Assets	174.93	290.6	60.66	53.25	77.09
Property, Plant & Equipment	6.32	10.66	10.61	12.44	7.81
Long-Term Deferred Charges	-	-	2.5	-	-
Other Long-Term Assets	5.91	3.39	1.42	1.23	0.59
Total Assets	187.16	304.65	75.2	66.92	85.49
Accounts Payable	3.02	4.62	4.36	1.45	0.77
Accrued Expenses	27.17	11.13	9.06	7.66	7.77
Current Portion of Leases	3.69	3.94	2.92	2.28	0.81
Current Unearned Revenue	-	-	-	-	6
Other Current Liabilities	-	14.06	3.52	0.57	0.58
Total Current Liabilities	33.87	33.76	19.86	11.95	15.93
Long-Term Leases	1.34	4.3	6.16	8.29	4.74
Long-Term Unearned Revenue	-	-	-	-	1.03
Other Long-Term Liabilities	-	-	-	0.01	1.33
Total Liabilities	35.21	38.06	26.02	20.25	23.02
Additional Paid-In Capital	538.94	530	4.64	1.71	0.53
Retained Earnings	-387.02	-263.52	-136.04	-75.68	-46.78
Comprehensive Income & Other	0.03	0.11	0	-0.03	-
Total Common Equity	151.95	266.59	-131.4	-74	-46.25
Shareholders' Equity	151.95	266.59	49.18	46.68	62.47
Total Liabilities & Equity	187.16	304.65	75.2	66.92	85.49
Total Debt	5.02	8.24	9.08	10.56	5.56
Net Cash (Debt)	166.11	277.74	48.46	40.76	70.51
Net Cash Growth	-46.84%	473.08%	18.91%	-42.20%	-
Net Cash Per Share	3.84	7.25	71.95	89.48	265.19
Filing Date Shares Outstanding	43.8	43.21	43.12	0.55	0.27
Total Common Shares Outstanding	43.79	43.21	1.25	0.55	0.27
Working Capital	141.05	256.85	40.81	41.3	61.16
Book Value Per Share	3.47	6.17	-105.11	-133.91	-173.96
Tangible Book Value	151.95	266.59	-131.4	-74	-46.25
Tangible Book Value Per Share	3.47	6.17	-105.11	-133.91	-173.96
Machinery	4.44	6.2	4.17	3.74	3.35
Leasehold Improvements	0.94	0.82	0.65	0.46	0.08

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q